Skip to main content
SHANDONG TEAMGENE TECHNOLOGY CO., LTD. logo

SHANDONG TEAMGENE TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603151 ISIN · CNE100005NN0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2025-11-11 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603151

About SHANDONG TEAMGENE TECHNOLOGY CO., LTD.

http://www.bangjigroup.com

Shandong Teamgene Technology Co., Ltd. specializes in the research, development, and manufacturing of advanced veterinary diagnostic products and molecular biology reagents. The company focuses on providing comprehensive solutions for animal health management, particularly in the detection and control of infectious diseases in livestock and poultry. Its product portfolio includes high-precision PCR test kits, nucleic acid extraction systems, and rapid diagnostic reagents designed for pathogens such as African Swine Fever and avian influenza. Teamgene serves a diverse clientele, including large-scale breeding enterprises, veterinary laboratories, and animal epidemic prevention centers. By leveraging biotechnology innovations, the company delivers technical support and diagnostic tools aimed at improving biosecurity and animal welfare within the agricultural sector.

Recent filings

Filing Released Lang Actions
山东邦基科技股份有限公司关于终止重大资产重组事项的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 山东邦基科技股份有限公司 regarding the termination of a major asset restructuring transaction. It details the background of the proposed transaction, the decision to terminate it, the board and independent directors' approval, and the impact on the company. The document references compliance with relevant laws and stock exchange rules, and it is a formal disclosure of a corporate action related to a major asset restructuring. It is not a full financial report, audit, or earnings release, nor is it a proxy statement or voting result. It is a regulatory announcement about the termination of a major asset restructuring transaction, which fits best under the category of Regulatory Filings (RNS) as it does not fit other more specific categories and is a formal disclosure of a corporate event.
2025-11-11 Chinese
山东邦基科技股份有限公司关于重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Shandong Bangji Technology Co., Ltd. regarding the progress of a major asset restructuring transaction. It details the transaction overview, historical disclosure timeline, current progress, and risk warnings. The document is relatively short (1780 characters) and focuses on updates about the ongoing transaction rather than providing full financial statements or detailed analysis. It is not a full annual or interim report, nor is it a final merger or acquisition filing. The content aligns with a Capital/Financing Update (CAP) as it concerns a significant asset acquisition and related financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-11-10 Chinese
山东邦基科技股份有限公司关于公司对外担保的进展公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement about the progress of external guarantees provided by the company to its subsidiaries and downstream dealers. It includes specifics on guarantee amounts, counterparties, internal approvals, and financial data related to the guarantees. It is not a full financial report, audit report, or earnings release. It is also not a notice of voting results, board changes, or a regulatory certification. The content focuses on the company's external guarantee activities and their status, which is a typical subject of a Regulatory Filing (RNS) in the context of corporate disclosures. The document length is over 5,000 characters and contains substantive information, but it does not fit into more specific categories like capital updates or legal proceedings. Therefore, the best classification is Regulatory Filings (RNS).
2025-11-06 Chinese
山东邦基科技股份有限公司2025年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '山东邦基科技股份有限公司 2025 年第三季度报告' which translates to 'Shandong Bangji Technology Co., Ltd. 2025 Third Quarter Report'. It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes for the third quarter of 2025. The report includes unaudited financial statements, management assurances about the accuracy of the report, and detailed shareholder information. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (the third quarter) clearly identifies this as an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, the correct classification is 'IR' (Interim / Quarterly Report). 9M 2025
2025-10-27 Chinese
山东邦基科技股份有限公司关于公司2025年第三季度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an announcement regarding the 2025 third quarter profit distribution plan by the company. It details the dividend per share, total dividend amount, and the decision-making process by the audit committee and board of directors. The document is short (1294 characters) and focuses on the dividend distribution plan rather than presenting full financial statements or comprehensive financial analysis. It is not a full quarterly report but an announcement of a dividend distribution plan related to the third quarter. Therefore, it fits best under the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related details for shareholders.
2025-10-27 Chinese
山东邦基科技股份有限公司关于召开2025年第三季度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of a 2025 third quarter earnings explanation meeting (业绩说明会) for 山东邦基科技股份有限公司. It specifies the date, time, location, and format of the meeting, as well as how investors can participate and ask questions. It references the prior release of the 2025 third quarter report but does not contain any financial data or analysis itself. The document is short (1417 characters) and serves as a notice for an upcoming investor call rather than the call transcript or the financial report. Therefore, it fits best as an Investor Presentation (IP) type, which covers detailed presentations for investors focusing on financials, strategy, and market position, especially since it is about an earnings explanation meeting. It is not a Call Transcript (CT) because it is a notice before the event, not the transcript after. It is not an Interim/Quarterly Report (IR) because it does not contain financial statements or substantive financial data. Hence, the classification is IP with high confidence.
2025-10-27 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.